ALLO Stock Performance and Key Statistics

ALLO has a current P/E ratio of -2.69

The ALLO stock has a trailing twelve month price-to sales (P/S) ratio of N/A while its price-to-book (P/B) value is 1.78.

ALLO's price-to-free-cashflow (P/FCF) ratio is -4.61, an indicator that is currently being trending upward.

Based on ALLO's recent bid, its distance from 20 days simple moving average is 40.54%. It is 62.62% apart from 50 days simple moving average, and it is 102.72% apart from 200 days simple moving average.

The 52-week high for ALLO is $4.46 which is 6.43% away from the current price level whereas the distance of that from the 52-week low of $0.98 stands at 216.67%.

The performance of ALLO stock was not encouraging with most of its significant price indicators in green. Allogene Therapeutics, Inc.(NASDAQ: ALLO) shares have moved downward -1.43% or - $0.03 in the latest trading session and have gained 14.6% year-to-date (YTD). The stock has lost nearly -14.67% over the past year. After moving 27.64% over the trailing 3-month period, the stock is 18.94% higher in the 6-month period. Looking at its performance over the shorter term, it'slost -5.99% a week and 10.56% a month.

The current 14-day RSI for ALLO stock is 75.84. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.

ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Allogene Therapeutics, Inc. (ALLO) has a 14-day ATR of 0.18.

After closing at $2.10 with 243.87M of its shares outstanding, the current enterprise value of ALLO is roughly 526.01M.

Allogene Therapeutics, Inc. (NASDAQ: ALLO) is down -14.67% when it comes to the percentage price change over the past 52-weeks. The percentage price change came less than that of broader S&P 500 index that came at a fall of 9.62%. ALLO stock price is also up 14.6% on its value in year-to-date trading.

The number outstanding shares of ALLO is 243.87M, and of these 74.36% shares are freely available for trading. On average, ALLO stock has traded 9.26M shares per day for the past 10 days. A total of 4.8M shares changed hands during the last trading session with the average session volume of 10.26M shares.